# In Good Company: Watch the Replay + Why Our Next Clinical Trial Matters | Sen-Jam Pharmaceutical

- Canonical URL: https://wefunder.com/feed/407246
- Entity ID: wefunder:feed_item:407246
- Published at: 2026-10-12 15:50:53 UTC
- Updated at: 2026-10-15 01:33:50 UTC

## Author
Christine Leonard

## Subject
Sen-Jam Pharmaceutical

## Content
Dear Sen-Jam Community,Great science takes great partners. And last Thursday, we had the pleasure of bringing two of ours together for our latest In Good Company webinar.Joining CEO Jim Iversen were Johann de Bruyn of TASK Clinical and Kiran Vepuri, EVP of Business Development at KVK-Tech, for a conversation about the partnerships, clinical expertise, and manufacturing capabilities helping move Sen-Jam's science toward medicines that can make a meaningful difference.Please note: this video recording is password protected. Password is: "partnerships" (I know. Of course it is).Why Our Next Clinical Trial Matters — Beyond One MedicineAs we advance toward our next Phase 2b clinical trial for SJP-001, we're focused on something bigger than progressing a single asset.Our earlier clinical work provided important safety data, promising exploratory signals, and invaluable lessons about how to design our next study. Phase 2b is where we aim to turn those learnings into stronger, prospectively defined clinical evidence.This study is designed to sharpen our understanding of how our combination works, how effectively it addresses multiple symptoms, and how best to measure meaningful patient improvement. Just as importantly, it will help inform the design of a more rigorous and potentially more successful Phase 3 program.And the opportunity extends beyond SJP-001. Each well-designed clinical study can build knowledge that informs our broader platform—from combination safety and dosing to the potential application of our inflammation-resolution approach across additional therapeutic opportunities.One study. Multiple insights. A stronger foundation for what comes next.Current Campaign Closing SoonWe invite you to invest in our activities at this important moment. Use the link HERE to explore our capital campaign in greater detail.Thank you for being part of the Sen-Jam journey and for believing in our mission to decode the biology of resilience.Warmly,ChristineThis communication is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to purchase securities. Any offering will be made only to eligible investors through the applicable offering documents, which should be reviewed carefully before making an investment decision. Forward-looking statements involve risks and uncertainties, and actual results may differ materially.